Pfizer in talks with India over approval for vaccine
ANI
03 May 2021, 19:18 GMT+10
New Delhi [India] May 3, (ANI): Pfizer is in discussions with the Indian government seeking an "expedited approval pathway" for its COVID-19 vaccine, CEO Albert Bourla said on Monday while announcing a donation of medicines worth 70 million USD to India.
"Unfortunately, our vaccine is not registered in India although our application was submitted months ago," Bourla, in a LinkedIn post, on Monday.
"We are currently discussing with the Indian government an expedited approval pathway to make our Pfizer-BioNTech vaccine available for use in the country.
"Pfizer group is committed to being a partner in India's fight against this disease and is quickly working to mobilize the largest humanitarian relief effort in our company's history," he added.